The knockdown of several Wnt signalling antagonists, like WIF1, Dkk, SFRP1, SOSTDC1 and IGFBP4 have been reported to play important roles in the aberrant Wnt signaling in ccRCC [10–13]. Here, SFRP1 is linked to nonpapillary renal cell carcinoma.